The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of "“Promising immunotherapeutic approaches for primary effusion lymphoma”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Victor A. Losay, Blossom Damania. Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases, Viruses. 2025; 17: 177. https://doi.org/10.3390/v17020177 |
|
2 |
2025 |
Soumaiah Abou Staiteieh, Nouria Faddoul, Berthe Hayar, Bilal Houshaymi, Nadine Darwiche, Raghida Abou Merhi. Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms, Expert Review of Anticancer Therapy. 2025; 25: 363. https://doi.org/10.1080/14737140.2025.2474728 |
|
3 |
2025 |
Lu Dai, Amrita Choudhary, Jiaojiao Fan, Lu Huang, Zhen Lin, Zhiqiang Qin. Identification of RP‐54745, an IL‐1 Inhibitor Displaying Anticancer Activities for KSHV‐Related Primary Effusion Lymphoma, Journal of Medical Virology. 2025; 97: e70200. https://doi.org/10.1002/jmv.70200 |
|
4 |
2024 |
Esther Niilonga Kalambi-Matengu, Elizabeth Botsile. 2024; https://doi.org/10.5772/intechopen.115534 |
|
5 |
2025 |
Miao Miao, Yuelei Chen, Xuehan Wang, Shengyang Li, Rong Hu. The critical role of ferroptosis in virus-associated hematologic malignancies and its potential value in antiviral-antitumor therapy, Virulence. 2025; 16: 2497908. https://doi.org/10.1080/21505594.2025.2497908 |